BeStock  
Markets › Compare › GPCR vs MNKD

GPCR vs MNKD

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GPCR · Structure Therapeutics$16.13 ▼ 5.78%
MNKD · MannKind$3.85 ▼ 2.53%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3193155217279Nov 24, '25May 26, '26Nov 20, '26
  • GPCR -54.3%
  • MNKD -25.0%

Head to head

MetricGPCRMNKD
Price$16.13$3.85
Change today▼ 5.78%▼ 2.53%
Market cap$1.15B$1.24B
Return, 3 months-67.1%-5.4%
Return, year to date-76.8%-32.1%
Return, 1 year-53.0%-23.5%
P/E (TTM)––
P/B0.9-33.2
P/E percentile vs own 5y99th26th
Dividend yield––
Revenue growth (YoY, latest qtr)–+24.0%
Net profit growth (YoY)-120.3%-390.8%
Gross margin–75.8%
Operating margin–-3.4%
Net margin–-18.1%
Return on equity-29.5%–
Analyst target vs. price+542.7%+120.8%
Analyst buy share100%88%
RSI (14)2252
30-day volatility61.9%51.9%
Max drawdown, 1 year-82.8%-63.3%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MNKD is the largest of the group by market value.
  • MNKD has returned the most over the past year.
  • MNKD has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top